2BB score and signals
Elicio Therapeutics, Inc.’s current 2BB score is 22 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 13 | Very Low |
| Momentum | 41 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 60 | Strong |
| Risk | 57 | Moderate |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 2011 |
| Employees | 33 |
| 52-week range | $2.66 – $16.00 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.4842 | — | $0.00 |
| 2026-08-05 | — | -0.5477 | — | $0.00 |
| 2026-05-11 | -0.65 | -0.4743 | $0.00 | $0.00 |
| 2026-03-12 | -0.45 | -0.4539 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish